Review
Aug 2026
SGLT2 inhibitors in autosomal dominant polycystic kidney disease: rationale, evidence gaps, and ongoing clinical trials.
L. Spatola, R. Maccarrone, Gaspare Oddo et al.
· International Urology and Ne... · 0 citations